Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maru Group is a global technology-enabled insights and market research firm that provides specialized services to the healthcare and life sciences sectors. The company operates through several divisions, including Maru/Matchbox and Maru/Health, offering deep expertise in understanding patient and physician behavior, market dynamics, and brand positioning. Utilizing its proprietary software platform, Maru/HUB, the group delivers real-time data and analytics to help pharmaceutical and biotech companies make informed commercial decisions. In 2022, Maru Group was acquired by Stagwell, integrating its capabilities into a broader global marketing and communications network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maru Group.